Trade Mark Journal No.2026/025 19 June 2026

UK00004399204 8 June 2026 (5)

Image for mark UK00004399204 SPARK
International priority date claimed: 22 January 2026 (United States of America) (99609468)
Class 5
Medicated and pharmaceutical preparations for use in the treatment of ADHD; prescription medicines for the treatment of ADHD.

Axsome Therapeutics, Inc.

Representative: Keltie LLP